Germany Neurology Devices Market Size

Germany Neurology Devices Market Analysis

The Germany neurology devices market is expected to grow with a CAGR of 7.8% in the forecast period.

The pandemic affected the studied market. Reorganizing stroke and neurological intensive care during the COVID-19 pandemic in Germany, a research study that was published in November 2021, stated that the coronavirus disease 19 (COVID-19) outbreak has dramatically forced healthcare systems to reorganize their departments, including neurological wards. The study compared how to stroke units, intermediate care units (IMC), and neurological intensive care units (ICUs) reorganized and implemented safety measures. A separate location was set up in 84.2% of hospitals for patients awaiting the results of their COVID-19 test, and 94.7% had a designated area for their management. In 36.8% of the institutions, outpatient care was even halted or cut by 63.2%. Thus, the market was adversely affected by the pandemic.

The key factors propelling the growth of the market are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, and an increase in R&D in the field of neuro therapies. The increasing incidence of neurological disorders like brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson's disease, peripheral neuropathy, and spinal cord tumors is expected to increase the market growth. For instance, according to the German Brain Tumor Association, 2020, 25% of all cancer diagnoses in the young involve tumors in the brain and central nervous system. According to the article published in the Journal of Global Health in February 2021, by Peige Songs, in Germany, the overall prevalence of Attention-deficit/hyperactivity disorder (ADHD) diagnosis was 4.8 % over a lifetime. As expected, there was a considerable gender gap between boys and girls (7.7%). (1.8 percent ). Thus, the increasing prevalence of ADHD is expected to rise the demand for neurology devices thereby boosting the market. Similarly, according to the article published in the Brain Behavior Immunology in August 2021, by Sofia Pappa, Anxiety was found to be prevalent in 23.2% of people, followed by depression in 22.08%, and, insomnia was found to be prevalent in 38.9% of the people. These diseases hamper the normal functioning of the brain thereby boosting the market for neurology devices. Thus, the abovementioned factors are expected to increase the market growth.

However, the high cost of the devices and stringent regulations and guidelines for new devices is restraining market growth.